PLUS THERAPEUTICS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Plus Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Plus Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -146 %, a 61.7% decline year-over-year.
  • Plus Therapeutics, Inc. annual Return On Assets for 2023 was -97.7 %, a 11.8% decline from 2022.
  • Plus Therapeutics, Inc. annual Return On Assets for 2022 was -87.4 %, a 40.1% decline from 2021.
  • Plus Therapeutics, Inc. annual Return On Assets for 2021 was -62.4 %, a 11% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -146 -55.9 -61.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -128 -38.1 -42.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -106 -5.88 -5.88% Jan 1, 2024 Mar 31, 2024
Q4 2023 -97.7 -10.3 -11.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -90.6 -7.93 -9.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -89.4 -14.7 -19.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -100 -35.7 -55.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -87.4 -25 -40.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -82.6 -15.1 -22.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -74.7 -5.82 -8.45% Apr 1, 2022 Jun 30, 2022
Q1 2022 -64.3 +6.26 +8.88% Jan 1, 2022 Mar 31, 2022
Q4 2021 -62.4 -6.17 -11% Oct 1, 2021 Dec 31, 2021
Q3 2021 -67.5 -45.9 -212% Jul 1, 2021 Sep 30, 2021
Q2 2021 -68.9 -61.6 -852% Apr 1, 2021 Jun 30, 2021
Q1 2021 -70.5 -25.7 -57.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -56.2 -3.4 -6.44% Oct 1, 2020 Dec 31, 2020
Q3 2020 -21.6 +45.7 +67.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -7.23 +74 +91.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -44.8 +2.2 +4.68% Jan 1, 2020 Mar 31, 2020
Q4 2019 -52.8 -1.69 -3.31% Oct 1, 2019 Dec 31, 2019
Q3 2019 -67.3 -12.2 -22.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -81.2 -17.3 -27.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -47 +19.7 +29.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -51.1 +24.3 +32.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -55.2 +20.5 +27.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -63.9 +7.56 +10.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -66.7 +0.67 +0.99% Jan 1, 2018 Mar 31, 2018
Q4 2017 -75.4 -15.5 -25.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -75.7 -22.7 -42.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -71.5 -38.2 -114% Apr 1, 2017 Jun 30, 2017
Q1 2017 -67.4 -62.1 -1165% Jan 1, 2017 Mar 31, 2017
Q4 2016 -60 -14.2 -30.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -53 -0.18 -0.34% Jul 1, 2016 Sep 30, 2016
Q2 2016 -33.3 +51.1 +60.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -5.33 +128 +96% Jan 1, 2016 Mar 31, 2016
Q4 2015 -45.8 +54.7 +54.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -52.8 +56.8 +51.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -84.5 +12.4 +12.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -134 -59.8 -81% Jan 1, 2015 Mar 31, 2015
Q4 2014 -101 -30.9 -44.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -110 -56.9 -108% Jul 1, 2014 Sep 30, 2014
Q2 2014 -96.9 -26.9 -38.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -73.9 +8.23 +10% Jan 1, 2014 Mar 31, 2014
Q4 2013 -69.6 +8.7 +11.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -52.7 +29 +35.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -70 -3.96 -6% Apr 1, 2013 Jun 30, 2013
Q1 2013 -82.1 -24.2 -41.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 -78.3 Oct 1, 2012 Dec 31, 2012
Q3 2012 -81.7 Jul 1, 2012 Sep 30, 2012
Q2 2012 -66 Apr 1, 2012 Jun 30, 2012
Q1 2012 -58 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.